Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulse Biosciences (PLSE) Leases (2020 - 2025)

Pulse Biosciences has reported Leases over the past 6 years, most recently at $6.3 million for Q3 2025.

  • Quarterly results put Leases at $6.3 million for Q3 2025, down 4.13% from a year ago — trailing twelve months through Sep 2025 was $6.3 million (down 4.13% YoY), and the annual figure for FY2024 was $7.2 million, down 1.28%.
  • Leases for Q3 2025 was $6.3 million at Pulse Biosciences, roughly flat from $6.3 million in the prior quarter.
  • Over the last five years, Leases for PLSE hit a ceiling of $9.3 million in Q1 2021 and a floor of $6.3 million in Q2 2025.
  • Median Leases over the past 5 years was $7.5 million (2023), compared with a mean of $7.7 million.
  • Peak annual rise in Leases hit 84.02% in 2021, while the deepest fall reached 23.12% in 2021.
  • Pulse Biosciences' Leases stood at $7.3 million in 2021, then increased by 11.11% to $8.1 million in 2022, then decreased by 10.0% to $7.3 million in 2023, then fell by 1.28% to $7.2 million in 2024, then fell by 11.82% to $6.3 million in 2025.
  • The last three reported values for Leases were $6.3 million (Q3 2025), $6.3 million (Q2 2025), and $6.9 million (Q1 2025) per Business Quant data.